XML 20 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income (loss) $ 160.3 $ (19.7) $ 111.3
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation of revenue earning equipment 378.9 350.5 343.7
Depreciation of property and equipment 46.8 39.7 39.6
Amortization of intangible assets 4.7 5.1 37.6
Amortization of deferred debt and financing obligations costs 6.4 5.6 4.5
Stock-based compensation charges 10.1 5.5 2.7
Gain on disposal of business 0.0   (50.9)
Impairment 29.7 0.0 0.0
Provision for receivables allowance 52.4 44.4 42.8
Deferred taxes (228.4) 12.3 22.3
Loss (gain) on sale of revenue earning equipment 1.2 21.5 (14.4)
Income from joint ventures (1.9) (2.3) (4.1)
Other 5.8 8.6 9.3
Changes in assets and liabilities:      
Receivables (131.6) (59.2) (20.1)
Inventory, prepaid and other assets (2.1) (19.0) (18.5)
Accounts payable (10.0) 9.2 (5.2)
Accrued liabilities and other long-term liabilities 19.4 31.2 (4.3)
Net cash provided by operating activities 341.7 433.4 496.3
Cash flows from investing activities:      
Net change in restricted cash and cash equivalents 7.0 0.0 3.2
Revenue earning equipment expenditures (501.4) (468.3) (600.0)
Proceeds from disposal of revenue earning equipment 160.1 115.4 151.9
Non-rental capital expenditures (74.6) (47.8) (76.9)
Proceeds from disposal of property and equipment 5.9 5.7 6.0
Proceeds from disposal of business 0.0 0.0 126.4
Other investing activities 0.0 0.0 (0.5)
Net cash used in investing activities (403.0) (395.0) (389.9)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 0.0 1,235.0 0.0
Repayments of long-term debt (247.0) 0.0 0.0
Proceeds from revolving lines of credit 561.9 1,791.0 1,865.0
Repayments on revolving lines of credit (339.2) (881.0) (2,208.6)
Proceeds from financing obligations 119.5 0.0 0.0
Principal payments under capital lease and financing obligations (16.7) (12.4) (10.0)
Proceeds from exercise of stock options and other 0.7 10.0 5.1
Net settlement on vesting of equity awards (0.1) (0.5) (5.0)
Proceeds from employee stock purchase plan 1.1 0.0 0.0
Purchase of treasury stock 0.0 0.0 (604.5)
Capital contributions from affiliates 0.0 0.0 198.8
Distributions and net transfers to THC 0.0 (2,071.9) 1,003.0
Net financing activities with affiliates 0.0 (67.4) (349.2)
Capital contributions from affiliates (2.7) (41.5) 0.0
Net cash provided by (used in) financing activities 77.5 (38.7) (105.4)
Effect of foreign exchange rate changes on cash and cash equivalents 1.3 (0.4) (4.3)
Net increase (decrease) in cash and cash equivalents during the period 17.5 (0.7) (3.3)
Cash and cash equivalents at beginning of period 24.0 24.7 28.0
Cash and cash equivalents at end of period 41.5 24.0 24.7
Supplemental disclosures of cash flow information:      
Cash paid for interest 131.7 70.7 27.7
Cash paid (refunded) for income taxes, net (5.5) 2.9 10.1
Supplemental disclosures of non-cash investing activity:      
Purchases of revenue earning equipment in accounts payable 22.8 15.1 0.0
Disposals of revenue earning equipment in accounts receivable 12.6 0.0 0.0
Non-rental capital expenditures in accounts payable 0.0 7.8 0.0
Supplemental disclosures of non-cash financing activity:      
Non-cash settlement of transactions with THC through equity 2.0 75.6 0.0
Supplemental disclosures of non-cash investing and financing activity:      
Equipment acquired through capital lease $ 0.4 $ 20.3 $ 0.0